The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients. (Articolo in rivista)

Type
Label
  • The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients. (Articolo in rivista) (literal)
Anno
  • 2001-01-01T00:00:00+01:00 (literal)
Alternative label
  • Montanaro D. 1, Sanna V. 3, Matarese G. 3, Larby B.B. 4, Racioppi L. 1, Carrieri P.B. 2, Bruno R. 2, Davey N.J. 4, Zappacosta S. 1, Fontana S. 3 (2001)
    The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients.
    in Clinical and experimental immunology (Print)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Montanaro D. 1, Sanna V. 3, Matarese G. 3, Larby B.B. 4, Racioppi L. 1, Carrieri P.B. 2, Bruno R. 2, Davey N.J. 4, Zappacosta S. 1, Fontana S. 3 (literal)
Pagina inizio
  • 288 (literal)
Pagina fine
  • 293 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 123 (literal)
Rivista
Note
  • ISI Web of Science (WOS) (literal)
Titolo
  • The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients. (literal)
Abstract
  • We studied the relationship between the HLA specificities associated with multiple sclerosis (MS) susceptibility in southern Italy and the reactivity of the human myelin basic protein (hMBP) immunogenic peptides 84-98 and 143-168, using short-term T-cell lines established from 9 MS patients and from 8 healthy individuals. In our population, DR15 was significantly associated with MS (34.9% in MS versus 13.7% in healthy controls, P < 0.05). This result is in agreement with the association found in northern Europe, but not with data obtained in a population from the island of Sardinia (Italy). In MS patients the frequency of reactive T-cell lines (TCL), tested for fine specificity against the immunodominant hMBP peptides 84-98 and 143-168, was increased for the hMBP 143-168 peptide (P < 0.05) but not for the 84-98 peptide. Although this reactivity was higher in DR15+ MS patients than in DR 15- MS patients, it seemed not to be associated with DR15 specificity in the MS population. Furthermore, there were no significant differences in frequency of reactive TCL to hMBP peptide 84-98 in DR15-positive or DR15-negative MS patients. Consequently, it appears that peptide 84-98, considered as a relevant autoantigen, is not implicated in the pathogenesis of MS in our population from southern Italy. (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
data.CNR.it